NANJING, China, April 21, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the first patient has been successfully ...

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit ...

The trial is evaluating VIR-5500 with an androgen receptor pathway inhibitor in early-line mCRPC and mHSPC.

This review argues that neurodegeneration is shaped not only by toxic protein buildup but also by immune signaling, with ...

ADAG stock outlook: single-asset bet on ADG126 masked anti-CTLA-4 cancer therapy, with AACR 2026 catalysts, partnerships, and ...